When it comes to integrating the pharma cold-chain, technology is invariably seen as having a big part to play. However, it can also form a big part of the problem. Here Alan Kennedy examines the virtues and limitations of technology when it comes to collaborative solutions.First of all, just in case I am in any danger of ruffling a few super-sensitive IT feathers, let me explain that I am a huge fan of technology and its capabilities when employed beneficially. Indeed, ever since I spent a ridi...
To continue reading this story get free access